US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Faeth Therapeutics

24.54

+0.54002.25%

Post-market: 24.560.0200+0.08%18:14 EDT

Volume:102.94K

Turnover:2.66M

Market Cap:632.61M

PE:-0.17

High:27.77

Open:24.05

Low:24.05

Close:24.00

52wk High:36.76

52wk Low:6.33

Shares:25.78M

Float Shares:811.70K

Volume Ratio:0.82

T/O Rate:12.68%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-142.7282

EPS(LYR):-16.7239

ROE:--

ROA:-95.24%

PB:-4.61

PE(LYR):-1.47

Loading ...

Overview Company News Filings

Sensei Biotherapeutics Inc : Btig Initiates Coverage With Buy Rating; Target Price $55

THOMSON REUTERS

Sensei Biotherapeutics initiated with a Buy at BTIG

Sensei Biotherapeutics Initiated at Buy by BTIG

Sensei Biotherapeutics Overhauls Capital Structure at 2026 Meeting

Sensei Biotherapeutics shareholders approve increase in authorized common shares to 300,000,000

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/FTH/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","market":"US","secType":"STK","nameCN":"Faeth Therapeutics","latestPrice":24.54,"timestamp":1782331200000,"preClose":24,"halted":0,"volume":102938,"hourTrading":{"tag":"盘后","latestPrice":24.56,"preClose":24.54,"latestTime":"18:14 EDT","volume":458,"amount":11242.240666,"timestamp":1782339274804,"change":0.02,"changeRate":0.000815,"amplitude":0.03097},"delay":0,"changeRate":0.022499999999999964,"floatShares":811700,"shares":25778800,"eps":-142.7282,"marketStatus":"Post-Mkt","change":0.54,"latestTime":"06-24 18:34:19 EDT","open":24.05,"high":27.77,"low":24.05,"amount":2658455.1710200002,"amplitude":0.155,"askPrice":28.8,"askSize":70,"bidPrice":24,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-142.7282,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1782345600000},"marketStatusCode":4,"adr":0,"listingDate":1612414800000,"exchange":"NASDAQ","adjPreClose":24,"preHourTrading":{"tag":"盘前","latestPrice":23.11,"preClose":24,"latestTime":"09:22 EDT","volume":56,"amount":1337.459928,"timestamp":1782307368421,"change":-0.89,"changeRate":-0.037083,"amplitude":0.037083},"postHourTrading":{"tag":"盘后","latestPrice":24.56,"preClose":24.54,"latestTime":"18:14 EDT","volume":458,"amount":11242.240666,"timestamp":1782339274804,"change":0.02,"changeRate":0.000815,"amplitude":0.03097},"volumeRatio":0.815264},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","floatShares":811700,"roa":"-95.24%","roe":"--","lyrEps":-16.72388,"volumeRatio":0.815264,"shares":25778800,"dividePrice":0,"high":27.77,"amplitude":0.155,"preClose":24,"low":24.05,"week52Low":6.325,"pbRate":"-4.61","week52High":36.76,"institutionHeld":0,"latestPrice":24.54,"committee":-0.75,"eps":-142.7282,"divideRate":0,"volume":102938,"delay":0,"ttmEps":-142.7282,"open":24.05,"prevYearClose":10.67,"prevWeekClose":17.82,"prevMonthClose":21.14,"prevQuarterClose":31.52,"fiveDayClose":14.53,"twentyDayClose":16.47,"sixtyDayClose":27.68},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-15","symbol":"FTH","fiscalQuarterEnding":"2026/03","expectedEps":-0.62,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-131.45},{"market":"US","date":"2026-03-30","symbol":"FTH","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"pre","actualEps":-3.74},{"market":"US","date":"2025-11-14","symbol":"FTH","fiscalQuarterEnding":"2025/09","expectedEps":-4.11,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-3.62},{"market":"US","date":"2025-08-05","symbol":"FTH","fiscalQuarterEnding":"2025/06","expectedEps":-6.2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-3.91},{"market":"US","date":"2025-06-17","symbol":"FTH","defaultRemindTime":1750167000000,"type":"split","dateTimestamp":1750132800000,"forFactor":20,"toFactor":1,"ratio":20}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FTH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1782187200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FTH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FTH","date":"2026-06-23","current":-0.18784,"percent":0,"low":-0.168709,"twenty":-0.145269,"median":-0.125386,"eighty":-0.114961,"high":-0.105707,"avg":-0.131297,"sd":0.023241,"marketCap":31119611},"quantilePoints":[{"date":"2026-06-18","current":-0.12113,"twenty":-0.118045,"median":-0.113419,"eighty":-0.108792,"marketCap":22343317},{"date":"2026-06-23","current":-0.168709,"twenty":-0.145269,"median":-0.125386,"eighty":-0.114961,"marketCap":31119611}],"updateTime":1782324193656},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FTH\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642285292","title":"Sensei Biotherapeutics Inc : Btig Initiates Coverage With Buy Rating; Target Price $55","url":"https://stock-news.laohu8.com/highlight/detail?id=2642285292","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642285292?lang=en_us&edition=fundamental","pubTime":"2026-06-11 18:37","pubTimestamp":1781174252,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nFWN42J0P1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FTH","SNSE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642850672","title":"Sensei Biotherapeutics initiated with a Buy at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2642850672","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642850672?lang=en_us&edition=fundamental","pubTime":"2026-06-11 18:31","pubTimestamp":1781173891,"startTime":"0","endTime":"0","summary":"BTIG initiated coverage of Sensei Biotherapeutics (SNSE) with a Buy rating and $55 price target The clinical-stage biotech company is advancing PIK...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sensei-biotherapeutics-initiated-with-a-buy-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sensei-biotherapeutics-initiated-with-a-buy-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PIK","BK4122","BK4139","FTH","BK4094","SNSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642285483","title":"Sensei Biotherapeutics Initiated at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2642285483","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642285483?lang=en_us&edition=fundamental","pubTime":"2026-06-11 18:30","pubTimestamp":1781173800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SNSE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 11, 2026 06:30 ET (10:30 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNSE","FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642471334","title":"Sensei Biotherapeutics Overhauls Capital Structure at 2026 Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2642471334","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642471334?lang=en_us&edition=fundamental","pubTime":"2026-06-11 05:45","pubTimestamp":1781127949,"startTime":"0","endTime":"0","summary":"The latest update is out from Sensei Biotherapeutics ( ($SNSE) ). On June 10, 2026, Sensei Biotherapeutics held its 2026 annual meeting of stockhol...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sensei-biotherapeutics-overhauls-capital-structure-at-2026-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sensei-biotherapeutics-overhauls-capital-structure-at-2026-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SNSE","BK4139","FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642947506","title":"Sensei Biotherapeutics shareholders approve increase in authorized common shares to 300,000,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2642947506","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642947506?lang=en_us&edition=fundamental","pubTime":"2026-06-11 04:21","pubTimestamp":1781122907,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics held its annual shareholder meeting on June 10, 2026.Shareholders authorized an increase in common stock authorized shares to 300,000,000 from 12,500,000; the charter amendment took effect June 10, 2026.Shareholders cleared issuance of common stock upon conversion of Series B Non-Voting Convertible Preferred Stock; conversion issuance was not reported as completed.Shareholders adopted the 2026 Equity Incentive Plan and the 2026 Employee Stock Purchase Plan; plan implementation actions were not reported as completed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sensei Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retri","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nNDL9cRwHZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FTH","SNSE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":25,"code":"91000000","status":"200"}]}}